News

AKF announces sponsorship from Novartis Pharmaceuticals Corporation for education and awareness campaigns for two rare kidney diseases: complement 3 glomerulopa...

AKF will present its poster "Barriers to genetic testing for determining cause of kidney disease among healthcare providers" at the American Society o...

As a part of its Unknown Causes of Kidney Disease (UCKD) Project, AKF surveyed health care providers to understand opportunities and barriers in diagnosing chro...

Spring summit will bring together scientists, patients and other stakeholders to drive innovation in diagnosis, research and treatment